NNVC - NanoViricides, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/29/2019
6/29/2018
6/29/2017
6/29/2016
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
5,993
5,922
4,827
5,532
5,029
Selling General and Administrative
2,616
2,738
4,498
4,069
3,831
Total Operating Expenses
8,608
8,660
9,325
9,601
8,860
Operating Income or Loss
-8,608
-8,660
-9,325
-9,601
-8,860
Interest Expense
-
0
544
2,129
2,470
Total Other Income/Expenses Net
426
180
1,206
1,364
542
Income Before Tax
-8,144
-8,424
-8,563
-10,304
-10,725
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-8,144
-8,424
-8,563
-10,304
-10,725
Net Income
-8,144
-8,424
-8,563
-10,304
-10,725
Net Income available to common shareholders
-8,144
-8,424
-8,563
-10,304
-10,725
Reported EPS
Basic
-
-2.40
-2.60
-3.40
-3.80
Diluted
-
-2.40
-2.60
-3.40
-3.80
Weighted average shares outstanding
Basic
-
3,590
3,246
3,005
2,883
Diluted
-
3,590
3,246
3,005
2,883
EBITDA
-
-7,729
-7,339
-7,513
-7,595